People | September 19, 2023
Biocon names Peter Bains as Group CEO
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Subscribe To Our Newsletter & Stay Updated
